90 related articles for article (PubMed ID: 20167381)
1. Encephalitogenic T-cells increase numbers of CNS T-cells regardless of antigen specificity by both increasing T-cell entry and preventing egress.
Lees JR; Sim J; Russell JH
J Neuroimmunol; 2010 Mar; 220(1-2):10-6. PubMed ID: 20167381
[TBL] [Abstract][Full Text] [Related]
2. T-cell trafficking competence is required for CNS invasion.
Lees JR; Archambault AS; Russell JH
J Neuroimmunol; 2006 Aug; 177(1-2):1-10. PubMed ID: 16822552
[TBL] [Abstract][Full Text] [Related]
3. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
4. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
5. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes.
Tan L; Gordon KB; Mueller JP; Matis LA; Miller SD
J Immunol; 1998 May; 160(9):4271-9. PubMed ID: 9574529
[TBL] [Abstract][Full Text] [Related]
6. CXCR3 blockade inhibits T-cell migration into the CNS during EAE and prevents development of adoptively transferred, but not actively induced, disease.
Sporici R; Issekutz TB
Eur J Immunol; 2010 Oct; 40(10):2751-61. PubMed ID: 21038468
[TBL] [Abstract][Full Text] [Related]
7. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
Li O; Liu JQ; Zhang H; Zheng P; Liu Y; Bai XF
Scand J Immunol; 2006 Aug; 64(2):117-24. PubMed ID: 16867156
[TBL] [Abstract][Full Text] [Related]
8. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis.
Krakowski ML; Owens T
Eur J Immunol; 1997 Nov; 27(11):2840-7. PubMed ID: 9394808
[TBL] [Abstract][Full Text] [Related]
9. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity.
Ponomarev ED; Shriver LP; Maresz K; Dittel BN
J Neurosci Res; 2005 Aug; 81(3):374-89. PubMed ID: 15959904
[TBL] [Abstract][Full Text] [Related]
10. Induction of EAE by T cells specific for alpha B-crystallin depends on prior viral infection in the CNS.
Verbeek R; van Dongen H; Wawrousek EF; Amor S; van Noort JM
Int Immunol; 2007 Mar; 19(3):277-85. PubMed ID: 17267417
[TBL] [Abstract][Full Text] [Related]
11. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
[TBL] [Abstract][Full Text] [Related]
12. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H
Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118
[TBL] [Abstract][Full Text] [Related]
13. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions.
Sobel RA; Kuchroo VK
J Immunol; 1992 Aug; 149(4):1444-51. PubMed ID: 1380045
[TBL] [Abstract][Full Text] [Related]
14. Limited repertoire of HLA-DRB1*0401-restricted MBP111-129-specific T cells in HLA-DRB1*0401 Tg mice and their pathogenic potential.
Huh J; Yao K; Quigley L; Ludwin SK; McFarland HF; Muraro PA; Martin R; Ito K
J Neuroimmunol; 2004 Jun; 151(1-2):94-102. PubMed ID: 15145608
[TBL] [Abstract][Full Text] [Related]
15. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic elimination of V beta 8.2+ cells from the central nervous system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of V beta 8.2+ encephalitogenic T cells.
Tabi Z; McCombe PA; Pender MP
Eur J Immunol; 1994 Nov; 24(11):2609-17. PubMed ID: 7957554
[TBL] [Abstract][Full Text] [Related]
17. gammadelta T cells express activation markers in the central nervous system of mice with chronic-relapsing experimental autoimmune encephalomyelitis.
Gao YL; Rajan AJ; Raine CS; Brosnan CF
J Autoimmun; 2001 Dec; 17(4):261-71. PubMed ID: 11771950
[TBL] [Abstract][Full Text] [Related]
18. Adoptively transferred EAE in gamma delta T cell-knockout mice.
Clark RB; Lingenheld EG
J Autoimmun; 1998 Feb; 11(1):105-10. PubMed ID: 9480728
[TBL] [Abstract][Full Text] [Related]
19. Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.
van Zwam M; Huizinga R; Heijmans N; van Meurs M; Wierenga-Wolf AF; Melief MJ; Hintzen RQ; 't Hart BA; Amor S; Boven LA; Laman JD
J Pathol; 2009 Mar; 217(4):543-51. PubMed ID: 19023878
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.
Körner H; Lemckert FA; Chaudhri G; Etteldorf S; Sedgwick JD
Eur J Immunol; 1997 Aug; 27(8):1973-81. PubMed ID: 9295034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
